跳至主要内容
临床试验/NL-OMON55751
NL-OMON55751招募中不适用

on-Alcoholic Fatty Liver Disease in children: determining the prevalence of liver fibrosis using FibroScan® - Fibrokids

Academisch Medisch Centrum0 个研究点目标入组 604 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
604

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 17(—)

入选标准

  • Age 8 - 18 years
  • Obesity (BMI >= 95th percentile) or overweight (BMI >= 85th and < 94th
  • percentile) with one of the following additional risk factors: central
  • adiposity, insulin resistance, prediabetes or diabetes, dyslipidemia, sleep
  • apnea, or family history of NAFLD/NASH.

排除标准

  • Age > 18 years
  • Other liver disease (viral/autoimmune hepatitis, M. Wilson, haemochromatosis,
  • alfa1-antitrypsine deficiency)
  • Metabolic disease (beta-oxidation defects, urea cyclus defects)
  • Alcohol consumption > 140 g/week
  • Use of steatogenic medication

研究者

相似试验